Autopsy report · NCT04519697

Mesenchymal Stem Cells for the Treatment of Rectovaginal Fistulas in Participants With Crohn's Disease

“PI left Cleveland Clinic”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 3 years 1 month before it stopped.
• 20 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1, Phase 2

Sponsor

Anthony Lembo

Sponsor type

University, hospital or other

Conditions

Rectovaginal Fistula; Crohn Disease; Crohn Disease of Vulva; Rectolabial; Fistula

Interventions

Mesenchymal Stem Cells; Placebo

Participants

20

Sites

1

Countries

United States

Trials that died the same way

• Post-marketing Surveillance Regarding Efficacy and Safety of SpaceOAR™
  “PI did leave hospital (retired)” (72% match in meaning)
• Decision-making and Risk-taking in Bulimia
  “The PI has left the hospital and no one is replacing him” (64% match in meaning)
• Risks for Insulin Resistance and Metabolic Syndrome Between Major Depressive Disorder (MDD) or MDD With Psychotic Features
  “PI left Massachusetts General Hospital Inpatient service” (63% match in meaning)
• Dexamethasone Administered Via the Epidural Catheter as an Adjunct in Patients Undergoing Cesarean Delivery
  “PI left Henry Ford Health before completion.” (62% match in meaning)
• Arabin Pessary Combine With Vaginal Progesterone Compare With Vaginal Progesterone Alone to Prevent Preterm Delivery in Singleton Pregnancies
  “Former PI Left the Institution” (62% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.